Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedran Radojcic

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancer Research|August 15, 2009
IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacityMaria Pletneva, Hongni Fan, Jang-June Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2009
STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine modelVedran Radojcic, Maria A Pletneva, Hung-Rong Yen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2015
Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantationSherri Wood, Jiane Feng, Jooho Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2019
Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4<sup>+</sup> T Cells in Graft-versus-Host DiseaseJooho Chung, Vedran Radojcic, Eric Perkey, et al.
Immunology|March 24, 2022
Adoptive transfer of IL-4 reprogrammed Tc17 cells elicits anti-tumour immunity through functional plasticityChiung-Hui Liu, Bo-Shiou Lin, Mei-Yao Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic CancerChuan-Teng Liu, Chun-Chieh Yeh, Tsai-Chen Wu, et al.
Blood|September 6, 2018
Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in miceVedran Radojcic, Katelyn Paz, Jooho Chung, et al.
Blood|September 28, 2010
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseYi Zhang, Ashley R Sandy, Jina Wang, et al.
The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer Research|August 15, 2009
IFN-producing killer dendritic cells are antigen-presenting cells endowed with T-cell cross-priming capacityMaria Pletneva, Hongni Fan, Jang-June Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2009
STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine modelVedran Radojcic, Maria A Pletneva, Hung-Rong Yen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2015
Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantationSherri Wood, Jiane Feng, Jooho Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2019
Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4<sup>+</sup> T Cells in Graft-versus-Host DiseaseJooho Chung, Vedran Radojcic, Eric Perkey, et al.
Immunology|March 24, 2022
Adoptive transfer of IL-4 reprogrammed Tc17 cells elicits anti-tumour immunity through functional plasticityChiung-Hui Liu, Bo-Shiou Lin, Mei-Yao Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 5, 2026
Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic CancerChuan-Teng Liu, Chun-Chieh Yeh, Tsai-Chen Wu, et al.
Blood|September 6, 2018
Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in miceVedran Radojcic, Katelyn Paz, Jooho Chung, et al.
Blood|September 28, 2010
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host diseaseYi Zhang, Ashley R Sandy, Jina Wang, et al.
The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Pageof 3